{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T19:56:16Z","timestamp":1781121376385,"version":"3.54.1"},"reference-count":68,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>\u201cAtypical squamous cells\u2013cannot exclude high-grade squamous intraepithelial lesion\u201d (ASC-H) cytology is uncommon (0.16%\u20130.43%). The reported risk of high-grade dysplasia varies greatly (12.00%\u201370.00%), making management challenging. Primary human papillomavirus (HPV) screening requires an updated understanding of ASC-H.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To review ASC-H colposcopic and histologic comparators, and management outcomes, to help guide future management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>A 1-year retrospective analysis of new ASC-H\u2013associated visits to a large colposcopy unit in Ireland in 2022 was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>\n                      The incidence of new ASC-H referrals was 3.63% (97 of 2672). The sensitivity of colposcopy for detection of high-grade changes (cervical intraepithelial neoplasia [CIN]2\n                      <jats:sup>+<\/jats:sup>\n                      ) is 69.39% (34 of 49) and the specificity is 43.18% (19 of 44). The positive predictive value is 64.15% (34 of 53) and the negative predictive value is 37.50% (15 of 40). High-grade dysplasia was identified in 53.26% (49 of 92) and adenocarcinoma in situ in 2.17% (2 of 92) of cases. Excisional treatment was performed for 52.58% (51 of 97) and cold coagulation for 12.37% (12 of 97) of cases. The test-of-cure result was HPV negative for 84.13%. High-risk HPV and abnormal cytology was seen in 9.52% (6 of 63) of cases, thus all required a second test-of-cure smear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>ASC-H with high-risk HPV has a 55.43% (51 of 92) risk of high-grade dysplasia, thus timely colposcopy and biopsy is imperative. Treatment was curative in 84.13% (53 of 63) to 96.83% (61 of 63) of cases, so it is an effective management strategy. Conservative management of selected cases may be a reasonable option.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2024-0423-oa","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T05:39:54Z","timestamp":1743140394000},"page":"1022-1026","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes and Management of Atypical Squamous Cells\u2013Cannot Exclude High-Grade Squamous Intraepithelial Lesion in a Primary Human Papillomavirus Screening System"],"prefix":"10.5858","volume":"149","author":[{"given":"Maria A.","family":"Cheung","sequence":"first","affiliation":[{"name":"From the Department of Colposcopy, Rotunda Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran D.","family":"McKeown","sequence":"additional","affiliation":[{"name":"From the Department of Colposcopy, Rotunda Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"From the Department of Colposcopy, Rotunda Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"5","key":"i1543-2165-149-11-1022-b01","series-title":"Int J Gynecol Cancer","first-page":"709","article-title":"Passion for saving lives: Turkey between 2012 and 2017","volume":"30","author":"Gultekin","year":"2020","unstructured":"Gultekin M,\nTuran SH,\nBoztas G,\n\u00d6zt\u00fcrk C,\nHacikamilo\u011flu E. Passion for saving lives: Turkey between 2012 and 2017. Int J Gynecol Cancer. 2020;30(5):709\u2013710. doi:10.1136\/ijgc-2019-001046"},{"issue":"5","key":"i1543-2165-149-11-1022-b02","series-title":"Clin Microbiol Infect","first-page":"579","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","unstructured":"Maver PJ,\nPoljak M. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. Clin Microbiol Infect. 2020;26(5):579\u2013583. doi:10.1016\/j.cmi.2019.09.006"},{"key":"i1543-2165-149-11-1022-b03","series-title":"The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes","author":"Nayar","year":"2015","unstructured":"Nayar R,\nWilbur DC. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. Springer; 2015."},{"key":"i1543-2165-149-11-1022-b04","series-title":"Cytojournal","first-page":"30):30","article-title":"The gray zone squamous lesions: ASC-US\/ASC-H","volume":"19","author":"Kattoor","year":"2022","unstructured":"Kattoor J,\nKamal MM. The gray zone squamous lesions: ASC-US\/ASC-H. Cytojournal. 2022;19(30):30. doi:10.25259\/CMAS_03_10_2021"},{"issue":"16","key":"i1543-2165-149-11-1022-b05","series-title":"JAMA","first-page":"2114","article-title":"The 2001 Bethesda System Terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","unstructured":"Solomon D. The 2001 Bethesda System Terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114. doi:10.1001\/jama.287.16.2114"},{"issue":"6","key":"i1543-2165-149-11-1022-b06","series-title":"JAMA","first-page":"547","article-title":"Cervical cancer screening: a review","volume":"330","author":"Perkins","year":"2023","unstructured":"Perkins RB,\nWentzensen N,\nGuido RS,\nSchiffman M. Cervical cancer screening: a review. JAMA. 2023;330(6):547\u2013558. doi:10.1001\/jama.2023.13174"},{"issue":"6","key":"i1543-2165-149-11-1022-b07","series-title":"J Am Soc Cytopathol","first-page":"248","article-title":"ASC-H cytological result: clinical relevance and accuracy of colposcopy in predicting high-grade histological lesions-a 7-year experience of a single institution in Portugal","volume":"6","author":"Marujo","year":"2017","unstructured":"Marujo AT,\nCorreia L,\nBrito M,\nPaula T,\nBorrego J. ASC-H cytological result: clinical relevance and accuracy of colposcopy in predicting high-grade histological lesions-a 7-year experience of a single institution in Portugal. J Am Soc Cytopathol. 2017;6(6):248\u2013253. doi:10.1016\/j.jasc.2017.07.004"},{"issue":"4","key":"i1543-2165-149-11-1022-b08","series-title":"J Am Soc Cytopathol","first-page":"225","article-title":"HPV testing results and histologic follow-up in women with ASC-H cytology in different age groups","volume":"4","author":"Chen","year":"2015","unstructured":"Chen L,\nBaker S,\nDe Petris G,\nYang B. HPV testing results and histologic follow-up in women with ASC-H cytology in different age groups. J Am Soc Cytopathol. 2015;4(4):225\u2013231. doi:10.1016\/j.jasc.2015.01.005"},{"issue":"9","key":"i1543-2165-149-11-1022-b09","series-title":"Cancer Cytopathol","first-page":"588","article-title":"Genotype profile of HPV in ASC-H cytology and histologic follow-up-prevalence, distribution, and risk: a retrospective study of 1414 cases","volume":"132","author":"Sun","year":"2024","unstructured":"Sun Y,\nWang T,\nZhong F, et al. Genotype profile of HPV in ASC-H cytology and histologic follow-up-prevalence, distribution, and risk: a retrospective study of 1414 cases. Cancer Cytopathol. 2024;132(9):588\u2013598. doi:10.1002\/cncy.22877"},{"key":"i1543-2165-149-11-1022-b10","series-title":"Prev Med","first-page":"61","article-title":"Population-based primary HPV mRNA cervical screening compared with cytology screening","volume":"124","author":"Lindroth","year":"2019","unstructured":"Lindroth Y,\nBorgfeldt C,\nThorn G,\nBodelsson G,\nForslund O. Population-based primary HPV mRNA cervical screening compared with cytology screening. Prev Med. 2019;124:61\u201366. doi:10.1016\/j.ypmed.2019.04.021"},{"issue":"1","key":"i1543-2165-149-11-1022-b11","series-title":"J Med Virol","first-page":"e28414","article-title":"Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: real-world data from regional cervical cancer screening program","volume":"95","author":"Ros\u00e1rio","year":"2023","unstructured":"Ros\u00e1rio A,\nSousa A,\nMarinho-Dias J, et al. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: real-world data from regional cervical cancer screening program. J Med Virol. 2023;95(1):e28414. doi:10.1002\/jmv.28414"},{"issue":"12","key":"i1543-2165-149-11-1022-b12","series-title":"Cancer Cytopathol","first-page":"939","article-title":"Inter- and intraobserver agreement in whole-slide digital ThinPrep samples of low-grade squamous lesions of the cervix uteri with known high-risk HPV status: a multicentric international study","volume":"130","author":"Kholov\u00e1","year":"2022","unstructured":"Kholov\u00e1 I,\nNegri G,\nNasioutziki M, et al. Inter- and intraobserver agreement in whole-slide digital ThinPrep samples of low-grade squamous lesions of the cervix uteri with known high-risk HPV status: a multicentric international study. Cancer Cytopathol. 2022;130(12):939\u2013948. doi:10.1002\/cncy.22624"},{"issue":"11","key":"i1543-2165-149-11-1022-b13","series-title":"JAMA","first-page":"1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","unstructured":"Stoler MH,\nSchiffman M, Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285(11):1500\u20131505. doi:10.1001\/jama.285.11.1500"},{"key":"i1543-2165-149-11-1022-b14","series-title":"J Low Genit Tract Dis","first-page":"206","article-title":"Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: review of ancillary testing modalities and implications for follow-up","volume":"14","author":"Davey","year":"2010","unstructured":"Davey D,\nGreenspan D,\nKurtycz D,\nHusain M,\nAustin RM. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: review of ancillary testing modalities and implications for follow-up. J Low Genit Tract Dis. 2010;14:206\u2013214. doi:10.1097\/LGT.0b013e3181ca66a6"},{"issue":"2","key":"i1543-2165-149-11-1022-b15","series-title":"J Low Genit Tract Dis","first-page":"102","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","unstructured":"Perkins RB,\nGuido RS,\nCastle PE, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2020;24(2):102\u2013131. doi:10.1097\/LGT.0000000000000525"},{"key":"i1543-2165-149-11-1022-b16","article-title":"Guidelines for Quality Assurance in Cervical Screening","author":"National Cancer Screening Service, Ireland","year":"2009","unstructured":"National Cancer Screening Service, Ireland. Guidelines for Quality Assurance in Cervical Screening. National Cancer Screening Service, Ireland. 2009. https:\/\/www.cervicalcheck.ie\/_fileupload\/Publications\/QA-finalprovide -web-version_69328305.pdf. Accessed February 6, 2025."},{"key":"i1543-2165-149-11-1022-b17","article-title":"Cervical Screening: Programme and Colposcopy Management","author":"NHS England","year":"2010","unstructured":"NHS England. Cervical Screening: Programme and Colposcopy Management. NHS England. 2010. https:\/\/www.gov.uk\/government\/publications\/cervical-screening-programme-and-colposcopy-management. Accessed February 6, 2025."},{"issue":"2","key":"i1543-2165-149-11-1022-b18","series-title":"Acta Cytol","first-page":"111","article-title":"The future role of cytology in cervical cancer screening in the era of HPV vaccination","volume":"67","author":"Barroeta","year":"2023","unstructured":"Barroeta JE. The future role of cytology in cervical cancer screening in the era of HPV vaccination. Acta Cytol. 2023;67(2):111\u2013118. doi:10.1159\/000528964"},{"issue":"2","key":"i1543-2165-149-11-1022-b19","series-title":"Eur J Cancer Prev","first-page":"158","article-title":"Establishment of a national cervical screening programme in Ireland, CervicalCheck: the first 6 years","volume":"27","author":"Flannelly","year":"2018","unstructured":"Flannelly GM,\nMooney MT,\nGreehy GM,\nKeogh EB,\nMcNally SA,\nFitzpatrick PE. Establishment of a national cervical screening programme in Ireland, CervicalCheck: the first 6 years. Eur J Cancer Prev. 2018;27(2):158\u2013163. doi:10.1097\/CEJ.0000000000000323"},{"issue":"4","key":"i1543-2165-149-11-1022-b20","series-title":"J Med Screen","first-page":"221","article-title":"The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening","volume":"26","author":"Aitken","year":"2019","unstructured":"Aitken CA,\nHoltzer-Goor KM,\nUyterlinde A, et al. The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening. J Med Screen. 2019;26(4):221\u2013224. doi:10.1177\/0969141319864991"},{"issue":"3","key":"i1543-2165-149-11-1022-b21","series-title":"Am J Clin Pathol","first-page":"391","article-title":"Knowledge of patients\u2019 human papillomavirus status at the time of cytologic review significantly affects the performance of cervical cytology in the ATHENA study","volume":"146","author":"Wright","year":"2016","unstructured":"Wright TC Jr,\nStoler MH,\nAslam S,\nBehrens CM. Knowledge of patients\u2019 human papillomavirus status at the time of cytologic review significantly affects the performance of cervical cytology in the ATHENA study. Am J Clin Pathol. 2016;146(3):391\u2013398. doi:10.1093\/ajcp\/aqw125"},{"issue":"4","key":"i1543-2165-149-11-1022-b22","series-title":"Am J Clin Pathol","first-page":"316","article-title":"Influence of prior knowledge of human papillomavirus status on the performance of cytology screening","volume":"149","author":"Martins","year":"2018","unstructured":"Martins TR,\nLongatto-Filho A,\nCohen D, et al. Influence of prior knowledge of human papillomavirus status on the performance of cytology screening. Am J Clin Pathol. 2018;149(4):316\u2013323. doi:10.1093\/ajcp\/aqx163"},{"issue":"7","key":"i1543-2165-149-11-1022-b23","series-title":"Cochrane Database Syst Rev","first-page":"CD008587","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"Koliopoulos","year":"2017","unstructured":"Koliopoulos G,\nNyaga VN,\nSantesso N, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017;8(7):CD008587. doi:10.1002\/14651858.CD008587.pub2"},{"issue":"12","key":"i1543-2165-149-11-1022-b24","series-title":"Arch Pathol Lab Med","first-page":"1874","article-title":"Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results","volume":"132","author":"Bandyopadhyay","year":"2008","unstructured":"Bandyopadhyay S,\nAustin RM,\nDabbs D,\nZhao C. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results. Arch Pathol Lab Med. 2008;132(12):1874\u20131881. doi:10.5858\/132.12.1874"},{"issue":"6","key":"i1543-2165-149-11-1022-b25","series-title":"Diagnostics (Basel)","first-page":"1066","article-title":"Predictors of CIN2+ in patients with PAP III-P (ASC-H): a cross-sectional study","volume":"13","author":"Kaiser","year":"2023","unstructured":"Kaiser LA,\nKupec T,\nNajjari L,\nStickeler E,\nWittenborn J. Predictors of CIN2+ in patients with PAP III-P (ASC-H): a cross-sectional study. Diagnostics (Basel). 2023;13(6):1066. doi:10.3390\/diagnostics13061066"},{"issue":"1","key":"i1543-2165-149-11-1022-b26","series-title":"Diagn Cytopathol","first-page":"1","article-title":"Atypical squamous cells, cannot exclude high grade intraepithelial lesion (ASC-H): does HPV matter","volume":"35","author":"Reid-Nicholson","year":"2007","unstructured":"Reid-Nicholson M,\nGatscha RM,\nRiedel ER,\nLin O. Atypical squamous cells, cannot exclude high grade intraepithelial lesion (ASC-H): does HPV matter? Diagn Cytopathol. 2007;35(1):1\u20135. doi:10.1002\/dc.20576"},{"key":"i1543-2165-149-11-1022-b27","series-title":"Poster\/ePoster Sessions","article-title":"#316 ASC-H cytological result: accuracy of colposcopy in predicting low-grade and high-grade histological lesions","author":"Sagni\u00e7","year":"2023","unstructured":"Sagni\u00e7 S,\nKaradag C,\nG\u00fcl SM,\nTuncer HA,\nDogan S,\nSimsek T. #316 ASC-H cytological result: accuracy of colposcopy in predicting low-grade and high-grade histological lesions. In: Poster\/ePoster Sessions. BMJ Publishing Group Ltd; 2023. doi:10.1136\/ijgc-2023-esgo.135"},{"issue":"4","key":"i1543-2165-149-11-1022-b28","series-title":"Arch Gynecol Obstet","first-page":"979","article-title":"Comparison of cure rates in women treated with cold-coagulation versus LLETZ cervical treatment for CIN2-3 on pretreatment cervical punch biopsies: a retrospective cohort study","volume":"295","author":"Papoutsis","year":"2017","unstructured":"Papoutsis D,\nUnderwood M,\nParry-Smith W,\nPanikkar J. Comparison of cure rates in women treated with cold-coagulation versus LLETZ cervical treatment for CIN2-3 on pretreatment cervical punch biopsies: a retrospective cohort study. Arch Gynecol Obstet. 2017;295(4):979\u2013986. doi:10.1007\/s00404-017-4306-z"},{"key":"i1543-2165-149-11-1022-b29","series-title":"Obstet Gynecol Int","first-page":"7955290","article-title":"Comparison of expectant and excisional\/ablative management of cervical intraepithelial neoplasia grade 2 (CIN2) in the era of HPV testing","volume":"2022","author":"Tjandraprawira","year":"2022","unstructured":"Tjandraprawira KD,\nOlaitan A,\nPetrie A,\nWilkinson N,\nRosenthal AN. Comparison of expectant and excisional\/ablative management of cervical intraepithelial neoplasia grade 2 (CIN2) in the era of HPV testing. Obstet Gynecol Int. 2022;2022:7955290. doi:10.1155\/2022\/7955290"},{"issue":"2","key":"i1543-2165-149-11-1022-b30","series-title":"J Obstet Gynaecol","first-page":"193","article-title":"Follow-up after negative large loop excision of the transformation zone (LLETZ) of the cervix","volume":"22","author":"Moselhi","year":"2002","unstructured":"Moselhi M,\nHowells REJ,\nHauke A,\nFiander A. Follow-up after negative large loop excision of the transformation zone (LLETZ) of the cervix. J Obstet Gynaecol. 2002;22(2):193\u2013196. doi:10.1080\/01443610120113409"},{"issue":"9","key":"i1543-2165-149-11-1022-b31","series-title":"BJOG","first-page":"1075","article-title":"How can the incidence of negative specimens resulting from large loop excision of the cervical transformation zone (LLETZ) be reduced: an analysis of negative LLETZ specimens and development of a predictive model","volume":"107","author":"Howells","year":"2000","unstructured":"Howells RE,\nO\u2019Mahony F,\nTucker H,\nMillinship J,\nJones PW,\nRedman CW. How can the incidence of negative specimens resulting from large loop excision of the cervical transformation zone (LLETZ) be reduced: an analysis of negative LLETZ specimens and development of a predictive model. BJOG. 2000;107(9):1075\u20131082. doi:10.1111\/j.1471-0528.2000.tb11103.x"},{"issue":"3","key":"i1543-2165-149-11-1022-b32","series-title":"J Low Genit Tract Dis","first-page":"212","article-title":"Outcomes of conservative management of high grade squamous intraepithelial lesions in young women","volume":"22","author":"Lee","year":"2018","unstructured":"Lee MH,\nFinlayson SJ,\nGukova K,\nHanley G,\nMiller D,\nSadownik LA. Outcomes of conservative management of high grade squamous intraepithelial lesions in young women. J Low Genit Tract Dis. 2018;22(3):212\u2013218. doi:10.1097\/LGT.0000000000000399"},{"key":"i1543-2165-149-11-1022-b33","series-title":"Eur J Obstet Gynecol Reprod Biol","first-page":"267","article-title":"Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: a cohort study","volume":"228","author":"Godfrey","year":"2018","unstructured":"Godfrey MAL,\nNikolopoulos M,\nGarner JE, et al. Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: a cohort study. Eur J Obstet Gynecol Reprod Biol. 2018;228:267\u2013273. doi:10.1016\/j.ejogrb.2018.07.018"},{"issue":"1","key":"i1543-2165-149-11-1022-b34","series-title":"BMC Infect Dis","first-page":"801","article-title":"Conservative management of CIN2 p16 positive lesions in women with multiple HPV infection","volume":"20","author":"Bruno","year":"2020","unstructured":"Bruno MT,\nScalia G,\nCassaro N,\nCostanzo M,\nBoemi S. Conservative management of CIN2 p16 positive lesions in women with multiple HPV infection. BMC Infect Dis. 2020;20(1):801. doi:10.1186\/s12879-020-05530-5"},{"issue":"5","key":"i1543-2165-149-11-1022-b01","series-title":"Int J Gynecol Cancer","first-page":"709","article-title":"Passion for saving lives: Turkey between 2012 and 2017","volume":"30","author":"Gultekin","year":"2020","unstructured":"Gultekin M,\nTuran SH,\nBoztas G,\n\u00d6zt\u00fcrk C,\nHacikamilo\u011flu E. Passion for saving lives: Turkey between 2012 and 2017. Int J Gynecol Cancer. 2020;30(5):709\u2013710. doi:10.1136\/ijgc-2019-001046"},{"issue":"5","key":"i1543-2165-149-11-1022-b02","series-title":"Clin Microbiol Infect","first-page":"579","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","unstructured":"Maver PJ,\nPoljak M. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. Clin Microbiol Infect. 2020;26(5):579\u2013583. doi:10.1016\/j.cmi.2019.09.006"},{"key":"i1543-2165-149-11-1022-b03","series-title":"The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes","author":"Nayar","year":"2015","unstructured":"Nayar R,\nWilbur DC. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. Springer; 2015."},{"key":"i1543-2165-149-11-1022-b04","series-title":"Cytojournal","first-page":"30):30","article-title":"The gray zone squamous lesions: ASC-US\/ASC-H","volume":"19","author":"Kattoor","year":"2022","unstructured":"Kattoor J,\nKamal MM. The gray zone squamous lesions: ASC-US\/ASC-H. Cytojournal. 2022;19(30):30. doi:10.25259\/CMAS_03_10_2021"},{"issue":"16","key":"i1543-2165-149-11-1022-b05","series-title":"JAMA","first-page":"2114","article-title":"The 2001 Bethesda System Terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","unstructured":"Solomon D. The 2001 Bethesda System Terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114. doi:10.1001\/jama.287.16.2114"},{"issue":"6","key":"i1543-2165-149-11-1022-b06","series-title":"JAMA","first-page":"547","article-title":"Cervical cancer screening: a review","volume":"330","author":"Perkins","year":"2023","unstructured":"Perkins RB,\nWentzensen N,\nGuido RS,\nSchiffman M. Cervical cancer screening: a review. JAMA. 2023;330(6):547\u2013558. doi:10.1001\/jama.2023.13174"},{"issue":"6","key":"i1543-2165-149-11-1022-b07","series-title":"J Am Soc Cytopathol","first-page":"248","article-title":"ASC-H cytological result: clinical relevance and accuracy of colposcopy in predicting high-grade histological lesions-a 7-year experience of a single institution in Portugal","volume":"6","author":"Marujo","year":"2017","unstructured":"Marujo AT,\nCorreia L,\nBrito M,\nPaula T,\nBorrego J. ASC-H cytological result: clinical relevance and accuracy of colposcopy in predicting high-grade histological lesions-a 7-year experience of a single institution in Portugal. J Am Soc Cytopathol. 2017;6(6):248\u2013253. doi:10.1016\/j.jasc.2017.07.004"},{"issue":"4","key":"i1543-2165-149-11-1022-b08","series-title":"J Am Soc Cytopathol","first-page":"225","article-title":"HPV testing results and histologic follow-up in women with ASC-H cytology in different age groups","volume":"4","author":"Chen","year":"2015","unstructured":"Chen L,\nBaker S,\nDe Petris G,\nYang B. HPV testing results and histologic follow-up in women with ASC-H cytology in different age groups. J Am Soc Cytopathol. 2015;4(4):225\u2013231. doi:10.1016\/j.jasc.2015.01.005"},{"issue":"9","key":"i1543-2165-149-11-1022-b09","series-title":"Cancer Cytopathol","first-page":"588","article-title":"Genotype profile of HPV in ASC-H cytology and histologic follow-up-prevalence, distribution, and risk: a retrospective study of 1414 cases","volume":"132","author":"Sun","year":"2024","unstructured":"Sun Y,\nWang T,\nZhong F, et al. Genotype profile of HPV in ASC-H cytology and histologic follow-up-prevalence, distribution, and risk: a retrospective study of 1414 cases. Cancer Cytopathol. 2024;132(9):588\u2013598. doi:10.1002\/cncy.22877"},{"key":"i1543-2165-149-11-1022-b10","series-title":"Prev Med","first-page":"61","article-title":"Population-based primary HPV mRNA cervical screening compared with cytology screening","volume":"124","author":"Lindroth","year":"2019","unstructured":"Lindroth Y,\nBorgfeldt C,\nThorn G,\nBodelsson G,\nForslund O. Population-based primary HPV mRNA cervical screening compared with cytology screening. Prev Med. 2019;124:61\u201366. doi:10.1016\/j.ypmed.2019.04.021"},{"issue":"1","key":"i1543-2165-149-11-1022-b11","series-title":"J Med Virol","first-page":"e28414","article-title":"Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: real-world data from regional cervical cancer screening program","volume":"95","author":"Ros\u00e1rio","year":"2023","unstructured":"Ros\u00e1rio A,\nSousa A,\nMarinho-Dias J, et al. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: real-world data from regional cervical cancer screening program. J Med Virol. 2023;95(1):e28414. doi:10.1002\/jmv.28414"},{"issue":"12","key":"i1543-2165-149-11-1022-b12","series-title":"Cancer Cytopathol","first-page":"939","article-title":"Inter- and intraobserver agreement in whole-slide digital ThinPrep samples of low-grade squamous lesions of the cervix uteri with known high-risk HPV status: a multicentric international study","volume":"130","author":"Kholov\u00e1","year":"2022","unstructured":"Kholov\u00e1 I,\nNegri G,\nNasioutziki M, et al. Inter- and intraobserver agreement in whole-slide digital ThinPrep samples of low-grade squamous lesions of the cervix uteri with known high-risk HPV status: a multicentric international study. Cancer Cytopathol. 2022;130(12):939\u2013948. doi:10.1002\/cncy.22624"},{"issue":"11","key":"i1543-2165-149-11-1022-b13","series-title":"JAMA","first-page":"1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","unstructured":"Stoler MH,\nSchiffman M, Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285(11):1500\u20131505. doi:10.1001\/jama.285.11.1500"},{"key":"i1543-2165-149-11-1022-b14","series-title":"J Low Genit Tract Dis","first-page":"206","article-title":"Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: review of ancillary testing modalities and implications for follow-up","volume":"14","author":"Davey","year":"2010","unstructured":"Davey D,\nGreenspan D,\nKurtycz D,\nHusain M,\nAustin RM. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: review of ancillary testing modalities and implications for follow-up. J Low Genit Tract Dis. 2010;14:206\u2013214. doi:10.1097\/LGT.0b013e3181ca66a6"},{"issue":"2","key":"i1543-2165-149-11-1022-b15","series-title":"J Low Genit Tract Dis","first-page":"102","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","unstructured":"Perkins RB,\nGuido RS,\nCastle PE, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2020;24(2):102\u2013131. doi:10.1097\/LGT.0000000000000525"},{"key":"i1543-2165-149-11-1022-b16","article-title":"Guidelines for Quality Assurance in Cervical Screening","author":"National Cancer Screening Service, Ireland","year":"2009","unstructured":"National Cancer Screening Service, Ireland. Guidelines for Quality Assurance in Cervical Screening. National Cancer Screening Service, Ireland. 2009. https:\/\/www.cervicalcheck.ie\/_fileupload\/Publications\/QA-finalprovide -web-version_69328305.pdf. Accessed February 6, 2025."},{"key":"i1543-2165-149-11-1022-b17","article-title":"Cervical Screening: Programme and Colposcopy Management","author":"NHS England","year":"2010","unstructured":"NHS England. Cervical Screening: Programme and Colposcopy Management. NHS England. 2010. https:\/\/www.gov.uk\/government\/publications\/cervical-screening-programme-and-colposcopy-management. Accessed February 6, 2025."},{"issue":"2","key":"i1543-2165-149-11-1022-b18","series-title":"Acta Cytol","first-page":"111","article-title":"The future role of cytology in cervical cancer screening in the era of HPV vaccination","volume":"67","author":"Barroeta","year":"2023","unstructured":"Barroeta JE. The future role of cytology in cervical cancer screening in the era of HPV vaccination. Acta Cytol. 2023;67(2):111\u2013118. doi:10.1159\/000528964"},{"issue":"2","key":"i1543-2165-149-11-1022-b19","series-title":"Eur J Cancer Prev","first-page":"158","article-title":"Establishment of a national cervical screening programme in Ireland, CervicalCheck: the first 6 years","volume":"27","author":"Flannelly","year":"2018","unstructured":"Flannelly GM,\nMooney MT,\nGreehy GM,\nKeogh EB,\nMcNally SA,\nFitzpatrick PE. Establishment of a national cervical screening programme in Ireland, CervicalCheck: the first 6 years. Eur J Cancer Prev. 2018;27(2):158\u2013163. doi:10.1097\/CEJ.0000000000000323"},{"issue":"4","key":"i1543-2165-149-11-1022-b20","series-title":"J Med Screen","first-page":"221","article-title":"The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening","volume":"26","author":"Aitken","year":"2019","unstructured":"Aitken CA,\nHoltzer-Goor KM,\nUyterlinde A, et al. The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening. J Med Screen. 2019;26(4):221\u2013224. doi:10.1177\/0969141319864991"},{"issue":"3","key":"i1543-2165-149-11-1022-b21","series-title":"Am J Clin Pathol","first-page":"391","article-title":"Knowledge of patients\u2019 human papillomavirus status at the time of cytologic review significantly affects the performance of cervical cytology in the ATHENA study","volume":"146","author":"Wright","year":"2016","unstructured":"Wright TC Jr,\nStoler MH,\nAslam S,\nBehrens CM. Knowledge of patients\u2019 human papillomavirus status at the time of cytologic review significantly affects the performance of cervical cytology in the ATHENA study. Am J Clin Pathol. 2016;146(3):391\u2013398. doi:10.1093\/ajcp\/aqw125"},{"issue":"4","key":"i1543-2165-149-11-1022-b22","series-title":"Am J Clin Pathol","first-page":"316","article-title":"Influence of prior knowledge of human papillomavirus status on the performance of cytology screening","volume":"149","author":"Martins","year":"2018","unstructured":"Martins TR,\nLongatto-Filho A,\nCohen D, et al. Influence of prior knowledge of human papillomavirus status on the performance of cytology screening. Am J Clin Pathol. 2018;149(4):316\u2013323. doi:10.1093\/ajcp\/aqx163"},{"issue":"7","key":"i1543-2165-149-11-1022-b23","series-title":"Cochrane Database Syst Rev","first-page":"CD008587","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"Koliopoulos","year":"2017","unstructured":"Koliopoulos G,\nNyaga VN,\nSantesso N, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017;8(7):CD008587. doi:10.1002\/14651858.CD008587.pub2"},{"issue":"12","key":"i1543-2165-149-11-1022-b24","series-title":"Arch Pathol Lab Med","first-page":"1874","article-title":"Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results","volume":"132","author":"Bandyopadhyay","year":"2008","unstructured":"Bandyopadhyay S,\nAustin RM,\nDabbs D,\nZhao C. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results. Arch Pathol Lab Med. 2008;132(12):1874\u20131881. doi:10.5858\/132.12.1874"},{"issue":"6","key":"i1543-2165-149-11-1022-b25","series-title":"Diagnostics (Basel)","first-page":"1066","article-title":"Predictors of CIN2+ in patients with PAP III-P (ASC-H): a cross-sectional study","volume":"13","author":"Kaiser","year":"2023","unstructured":"Kaiser LA,\nKupec T,\nNajjari L,\nStickeler E,\nWittenborn J. Predictors of CIN2+ in patients with PAP III-P (ASC-H): a cross-sectional study. Diagnostics (Basel). 2023;13(6):1066. doi:10.3390\/diagnostics13061066"},{"issue":"1","key":"i1543-2165-149-11-1022-b26","series-title":"Diagn Cytopathol","first-page":"1","article-title":"Atypical squamous cells, cannot exclude high grade intraepithelial lesion (ASC-H): does HPV matter","volume":"35","author":"Reid-Nicholson","year":"2007","unstructured":"Reid-Nicholson M,\nGatscha RM,\nRiedel ER,\nLin O. Atypical squamous cells, cannot exclude high grade intraepithelial lesion (ASC-H): does HPV matter? Diagn Cytopathol. 2007;35(1):1\u20135. doi:10.1002\/dc.20576"},{"key":"i1543-2165-149-11-1022-b27","series-title":"Poster\/ePoster Sessions","article-title":"#316 ASC-H cytological result: accuracy of colposcopy in predicting low-grade and high-grade histological lesions","author":"Sagni\u00e7","year":"2023","unstructured":"Sagni\u00e7 S,\nKaradag C,\nG\u00fcl SM,\nTuncer HA,\nDogan S,\nSimsek T. #316 ASC-H cytological result: accuracy of colposcopy in predicting low-grade and high-grade histological lesions. In: Poster\/ePoster Sessions. BMJ Publishing Group Ltd; 2023. doi:10.1136\/ijgc-2023-esgo.135"},{"issue":"4","key":"i1543-2165-149-11-1022-b28","series-title":"Arch Gynecol Obstet","first-page":"979","article-title":"Comparison of cure rates in women treated with cold-coagulation versus LLETZ cervical treatment for CIN2-3 on pretreatment cervical punch biopsies: a retrospective cohort study","volume":"295","author":"Papoutsis","year":"2017","unstructured":"Papoutsis D,\nUnderwood M,\nParry-Smith W,\nPanikkar J. Comparison of cure rates in women treated with cold-coagulation versus LLETZ cervical treatment for CIN2-3 on pretreatment cervical punch biopsies: a retrospective cohort study. Arch Gynecol Obstet. 2017;295(4):979\u2013986. doi:10.1007\/s00404-017-4306-z"},{"key":"i1543-2165-149-11-1022-b29","series-title":"Obstet Gynecol Int","first-page":"7955290","article-title":"Comparison of expectant and excisional\/ablative management of cervical intraepithelial neoplasia grade 2 (CIN2) in the era of HPV testing","volume":"2022","author":"Tjandraprawira","year":"2022","unstructured":"Tjandraprawira KD,\nOlaitan A,\nPetrie A,\nWilkinson N,\nRosenthal AN. Comparison of expectant and excisional\/ablative management of cervical intraepithelial neoplasia grade 2 (CIN2) in the era of HPV testing. Obstet Gynecol Int. 2022;2022:7955290. doi:10.1155\/2022\/7955290"},{"issue":"2","key":"i1543-2165-149-11-1022-b30","series-title":"J Obstet Gynaecol","first-page":"193","article-title":"Follow-up after negative large loop excision of the transformation zone (LLETZ) of the cervix","volume":"22","author":"Moselhi","year":"2002","unstructured":"Moselhi M,\nHowells REJ,\nHauke A,\nFiander A. Follow-up after negative large loop excision of the transformation zone (LLETZ) of the cervix. J Obstet Gynaecol. 2002;22(2):193\u2013196. doi:10.1080\/01443610120113409"},{"issue":"9","key":"i1543-2165-149-11-1022-b31","series-title":"BJOG","first-page":"1075","article-title":"How can the incidence of negative specimens resulting from large loop excision of the cervical transformation zone (LLETZ) be reduced: an analysis of negative LLETZ specimens and development of a predictive model","volume":"107","author":"Howells","year":"2000","unstructured":"Howells RE,\nO\u2019Mahony F,\nTucker H,\nMillinship J,\nJones PW,\nRedman CW. How can the incidence of negative specimens resulting from large loop excision of the cervical transformation zone (LLETZ) be reduced: an analysis of negative LLETZ specimens and development of a predictive model. BJOG. 2000;107(9):1075\u20131082. doi:10.1111\/j.1471-0528.2000.tb11103.x"},{"issue":"3","key":"i1543-2165-149-11-1022-b32","series-title":"J Low Genit Tract Dis","first-page":"212","article-title":"Outcomes of conservative management of high grade squamous intraepithelial lesions in young women","volume":"22","author":"Lee","year":"2018","unstructured":"Lee MH,\nFinlayson SJ,\nGukova K,\nHanley G,\nMiller D,\nSadownik LA. Outcomes of conservative management of high grade squamous intraepithelial lesions in young women. J Low Genit Tract Dis. 2018;22(3):212\u2013218. doi:10.1097\/LGT.0000000000000399"},{"key":"i1543-2165-149-11-1022-b33","series-title":"Eur J Obstet Gynecol Reprod Biol","first-page":"267","article-title":"Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: a cohort study","volume":"228","author":"Godfrey","year":"2018","unstructured":"Godfrey MAL,\nNikolopoulos M,\nGarner JE, et al. Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: a cohort study. Eur J Obstet Gynecol Reprod Biol. 2018;228:267\u2013273. doi:10.1016\/j.ejogrb.2018.07.018"},{"issue":"1","key":"i1543-2165-149-11-1022-b34","series-title":"BMC Infect Dis","first-page":"801","article-title":"Conservative management of CIN2 p16 positive lesions in women with multiple HPV infection","volume":"20","author":"Bruno","year":"2020","unstructured":"Bruno MT,\nScalia G,\nCassaro N,\nCostanzo M,\nBoemi S. Conservative management of CIN2 p16 positive lesions in women with multiple HPV infection. BMC Infect Dis. 2020;20(1):801. doi:10.1186\/s12879-020-05530-5"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/149\/11\/article-p1022.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/149\/11\/1022\/3543930\/i1543-2165-149-11-1022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/149\/11\/article-p1022.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/149\/11\/article-p1022.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:14:32Z","timestamp":1770772472000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/149\/11\/article-p1022.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":68,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2024-0423-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}